148 related articles for article (PubMed ID: 37886483)
1. Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.
Gurrea-Rubio M; Wu Q; Amin MA; Tsou PS; Campbell PL; Amarista CE; Ikari Y; Brodie WD; Mattichak MN; Muraoka S; Randon PM; Lind ME; Ruth JH; Mao-Draayer Y; Ding S; Shen X; Cooney LA; Lin F; Fox DA
Res Sq; 2023 Oct; ():. PubMed ID: 37886483
[TBL] [Abstract][Full Text] [Related]
2. Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Gurrea-Rubio M; Wu Q; Amin MA; Tsou PS; Campbell PL; Amarista CI; Ikari Y; Brodie WD; Mattichak MN; Muraoka S; Randon PM; Lind ME; Ruth JH; Mao-Draayer Y; Ding S; Shen X; Cooney LA; Lin F; Fox DA
Cancer Immunol Immunother; 2024 Jan; 73(2):34. PubMed ID: 38280067
[TBL] [Abstract][Full Text] [Related]
3. CD6 is a target for cancer immunotherapy.
Ruth JH; Gurrea-Rubio M; Athukorala KS; Rasmussen SM; Weber DP; Randon PM; Gedert RJ; Lind ME; Amin MA; Campbell PL; Tsou PS; Mao-Draayer Y; Wu Q; Lanigan TM; Keshamouni VG; Singer NG; Lin F; Fox DA
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497367
[TBL] [Abstract][Full Text] [Related]
4. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
[TBL] [Abstract][Full Text] [Related]
5. CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies.
Aragón-Serrano L; Carrillo-Serradell L; Planells-Romeo V; Isamat M; Velasco-de Andrés M; Lozano F
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139340
[TBL] [Abstract][Full Text] [Related]
6. CD318 is a ligand for CD6.
Enyindah-Asonye G; Li Y; Ruth JH; Spassov DS; Hebron KE; Zijlstra A; Moasser MM; Wang B; Singer NG; Cui H; Ohara RA; Rasmussen SM; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6912-E6921. PubMed ID: 28760953
[TBL] [Abstract][Full Text] [Related]
7. Clinical and experimental evidence for targeting CD6 in immune-based disorders.
Consuegra-Fernández M; Lin F; Fox DA; Lozano F
Autoimmun Rev; 2018 May; 17(5):493-503. PubMed ID: 29526637
[TBL] [Abstract][Full Text] [Related]
8. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
9. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress.
Orlik C; Berschneider KM; Jahraus B; Niesler B; Balta E; Schäkel K; Schröder-Braunstein J; Souto-Carneiro MM; Samstag Y
Front Immunol; 2022; 13():1016112. PubMed ID: 36353616
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.
Li Y; Ruth JH; Rasmussen SM; Athukorala KS; Weber DP; Amin MA; Campbell PL; Singer NG; Fox DA; Lin F
Arthritis Rheumatol; 2020 Sep; 72(9):1505-1513. PubMed ID: 32307907
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
Front Immunol; 2022; 13():967944. PubMed ID: 36159854
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs.
de Bruin TG; van Rooij EM; de Visser YE; Voermans JJ; Samsom JN; Kimman TG; Bianchi AT
J Gen Virol; 2000 Jun; 81(Pt 6):1529-37. PubMed ID: 10811936
[TBL] [Abstract][Full Text] [Related]
15. CD166-specific CAR-T cells potently target colorectal cancer cells.
He S; Li S; Guo J; Zeng X; Liang D; Zhu Y; Li Y; Yang D; Zhao X
Transl Oncol; 2023 Jan; 27():101575. PubMed ID: 36327697
[TBL] [Abstract][Full Text] [Related]
16. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
18. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
19. The dual role of CD6 as a therapeutic target in cancer and autoimmune disease.
Gurrea-Rubio M; Fox DA
Front Med (Lausanne); 2022; 9():1026521. PubMed ID: 36275816
[TBL] [Abstract][Full Text] [Related]
20. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
